LIDOCAINE
Fentanyl
Aretaieion University HospitalSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Fentanyl cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MIVACURIUM ION St. Antonius Hospital | Phase 4 | BB |
PROPOFOL St. Antonius Hospital | Phase 4 | BB |
RAMIFENTANYL Aretaieion University Hospital | Phase 4 | BB |
FENTANYL Helwan University | Phase 4 | BB |
Bxcl501 Aretaieion University Hospital | N/A | D |
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE Aretaieion University Hospital | N/A | D |
Same molecule, other indications
LIDOCAINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →